Welcome to our dedicated page for Genpact news (Ticker: G), a resource for investors and traders seeking the latest updates and insights on Genpact stock.
Genpact Limited (NYSE: G) delivers transformative business solutions through digital innovation and process excellence. This news hub provides investors and professionals with essential updates about the company's strategic initiatives, operational developments, and market leadership in business process management.
Access real-time announcements including quarterly earnings disclosures, partnership agreements, technology implementations, and corporate governance updates. Our curated collection ensures you stay informed about Genpact's progress in key focus areas like Data-Tech-AI integration, enterprise transformation projects, and industry-specific solutions across banking, healthcare, and manufacturing sectors.
Discover press releases detailing operational milestones, executive leadership changes, and client success stories. The archive serves as a vital resource for tracking Genpact's commitment to enhancing business agility through intelligent automation and process optimization strategies.
Bookmark this page for continuous access to verified corporate communications and analysis of Genpact's evolving role in shaping digital-first enterprise operations worldwide.
Genpact Limited (NYSE: G) reported strong financial performance for Q1 2021, with total revenue reaching $946 million, a 2.5% year-over-year increase. Revenue from Global Clients was $853 million, up 6%. Despite a 24% decline in revenue from GE, the company saw a net income rise of 7% to $91 million. Adjusted diluted EPS improved by 11% to $0.59. Genpact anticipates annual revenue between $3.93 to $3.99 billion and adjusted diluted EPS of $2.27 to $2.30, reflecting positive growth outlook. The firm also repurchased shares worth $134 million during the quarter.
Genpact Limited (NYSE: G) has declared a cash dividend of $0.1075 per common share for the second quarter of 2021. This dividend is payable on June 23, 2021 to shareholders on record as of the close of business on June 11, 2021. Future dividends will be determined at the discretion of the board. This announcement reflects Genpact's commitment to returning value to shareholders amidst ongoing digital transformation efforts.
Genpact (NYSE: G) has partnered with Fast Company to enhance the World Changing Ideas (WCI) platform, focusing on digital transformation. This year, Genpact will assist one winning organization with a 'digital makeover' aimed at amplifying its societal impact. Together, they will select an honoree from Fast Company's 2021 awards to undergo this transformation, which will be documented across various media platforms. Both organizations emphasize the pivotal role of technology in driving meaningful change in the current landscape.
Genpact (NYSE: G) has been recognized as a leader in the Forrester Wave™: Insights-driven Business Process Outsourcing, Q4 2020 report. The firm received the highest scores in eight criteria, including vision and partner ecosystem. Forrester highlighted Genpact's capabilities in advanced analytics and automation, praising its ability to deliver insights as a service. Genpact's digital platform, Genpact Cora, along with strong client engagements, showcases its commitment to driving digital transformation for Global Fortune 500 companies.
Genpact (NYSE: G) will announce its first-quarter results for the period ending March 31, 2021, on May 10, 2021, after U.S. market close. Following this, a conference call will occur at 4:30 p.m. ET to discuss performance. Interested participants can dial in or join via a live webcast on Genpact's Investor Relations website. This earnings call is vital for investors seeking to understand Genpact's financial health and future outlook.
Genpact (NYSE: G) announced the appointment of Tamara Franklin, former Chief Digital, Data, and Analytics Officer at Marsh LLC, to its Board of Directors, effective March 29, 2021. Franklin's extensive experience in digital transformation and leadership roles at IBM and Scripps Networks Interactive is expected to enhance Genpact's strategic initiatives. Chairman Jim Madden and CEO Tiger Tyagarajan expressed optimism about her contributions, emphasizing her expertise in driving innovation and client experience.
On March 24, 2021, Genpact (NYSE: G), alongside the Creative Destruction Lab Rapid Screening Consortium and the COVID Collaborative, launched the U.S. Rapid Action Consortium. This initiative aims to fast-track safe, cost-effective COVID-19 testing to facilitate business reopenings. The Consortium publicizes its findings and testing protocols to support workplaces across the U.S., inspired by a successful Canadian model. The first cohort of participating companies is set to commence on April 5, 2021, amid rising urgency for systematic rapid testing as the economy faces significant losses.
Genpact Limited (NYSE: G) announced a $350 million public offering of 1.750% senior notes due 2026, priced by its subsidiaries, Genpact Luxembourg and Genpact USA. The offering is expected to close on March 26, 2021, pending customary conditions. The proceeds may be used for general corporate purposes, including repaying existing debt. The offering is part of an effective shelf registration with the SEC. Genpact emphasizes its commitment to digital transformation and innovation across its operations, serving numerous Global Fortune 500 clients.
Commonwealth Informatics, a subsidiary of Genpact, launched an upgraded version of its Commonwealth Vigilance Workbench (CVW) on March 22, 2021. This cloud-based solution aims to enhance drug safety through advanced AI and analytics, benefiting life sciences and regulatory agencies. Two major global pharmaceutical companies have implemented the new CVW, which streamlines signal detection and management of adverse drug effects. The latest enhancements improve data review, signal tracking, and report generation. Commonwealth's focus on pharmacovigilance is timely, given the ongoing COVID-19 pandemic.
Genpact (NYSE:G) has secured two patents from the U.S. Patent and Trademark Office for innovative business transformation frameworks: Genpact ProcIndex and Intelligent Automation Index. ProcIndex measures process health using analytics, helping companies identify improvement opportunities, while the Intelligent Automation Index assesses automation potential across processes. By leveraging these tools, Genpact enables firms to drive operational efficiency and optimize ROI. Both frameworks have been successfully implemented by over 100 clients, leading to significant improvements in process efficiency and cost reduction.
FAQ
What is the current stock price of Genpact (G)?
What is the market cap of Genpact (G)?
